8 results
COVID-19 Diagnosis and Management Summary
Clinical and laboratory testing
Lung Ultrasound
HRCT scan
In-hospital treatment
Severity assessment and respiratory support 
Post-mortem
COVID-19 Diagnosis ... and Management ... Summary Clinical ... laboratory testing Lung ... Ultrasound HRCT
COVID-19 POCUS

96 yrs old, discharged 3 wks ago for CAP, treated with amox/clav then cefixime. Returns
Returns for dyspnea ... But this ultrasound ... #POCUS #Clinical ... #Lung #Ultrasound ... #SARSCoV2 #Coronavirus
COVID-19 on POCUS

I am infected with COVID-19. This is my own #POCUS 2 days after the
COVID-19 on POCUS ... No feeling of dyspnea ... #POCUS #Clinical ... #Lung #Ultrasound ... #SARSCoV2 #Coronavirus
COVID19 vs CHF on POCUS

Spot the difference. 2 pts presenting with nearly same symptoms. Left COVID
COVID19 vs CHF on ... Left COVID pneumonia ... #POCUS #Clinical ... #Lung #Ultrasound ... #SARSCoV2 #Coronavirus
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
of interstitial lung ... - Clinical manifestations ... History: cough, dyspnea ... Treatment: • ... ILD #diagnosis #management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... cause: Aspiration pneumonia ... for Klebsiella pneumonia ... Lung Abscess - Clinical ... pain, hemoptysis, dyspnea
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... hemoptysis • Dyspnea ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... hemoptysis • Dyspnea ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB